Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8209184 | Applied Radiation and Isotopes | 2016 | 8 Pages |
Abstract
Clomiphene has growth-inhibitory effects of breast cancer cells, clomiphene was successfully labeled with 125I via direct electrophilic substitution reaction with labeling yield 97%. It was obtained at optimum substrate amount of 0.5 mg, Chloramine-T was used as an oxidizing agent at optimum amount of 25 µg. Labeling reactions was done at pH 5 at ambient temperature. This study showed good in vitro and in vivo stability of the 125I-clomiphene. The radiolabeled compound showed high ascetic fluid uptake of 18.12±0.27% at 30 min post-injection. Solid tumor uptake of 125I-clomiphene was 12.48±0.32% at 30 min post-injection. This data revealed the localization of tracer in tumor tissue with high percent sufficient to use 125I-clomiphene as a promising tool for the diagnosis of breast cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
I.T. Ibrahim, M.T. El-Kolaly, M.H. Aboumanei, A. Abdelbary,